Literature DB >> 24714375

Epigenetic mechanisms in the pathogenesis of diabetic retinopathy.

Jun Zeng1, Baihua Chen.   

Abstract

Diabetic retinopathy (DR), which arises as a result of an increasing incidence of diabetes mellitus, has gradually become a common disease. Due to its complex pathogenesis, the treatment means of DR are very limited. The findings of several studies have shown that instituting tight glycemic control in diabetic patients does not immediately benefit the progression of retinopathy, and the benefits of good control persist beyond the period of good glycemic control. This has led to the concept of persistent epigenetic changes. Epigenetics has now become an increasingly important area of biomedical research. Recently, important roles of various epigenetic mechanisms have been identified in the pathogenesis of diabetes and its complications. The aim of this review is to provide an overview of the epigenetics and epigenetic mechanisms in diabetes and diabetes complications, and the focus is on the emerging evidence for aberrant epigenetic mechanisms in DR.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24714375     DOI: 10.1159/000357824

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  8 in total

1.  Novel Genetic Actors of Diabetes-Associated Microvascular Complications: Retinopathy, Kidney Disease and Neuropathy.

Authors:  Samaneh Davoudi; Lucia Sobrin
Journal:  Rev Diabet Stud       Date:  2016-01-25

Review 2.  Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis.

Authors:  Rubens P Homme; Mahavir Singh; Avisek Majumder; Akash K George; Kavya Nair; Harpal S Sandhu; Neetu Tyagi; David Lominadze; Suresh C Tyagi
Journal:  Front Physiol       Date:  2018-09-05       Impact factor: 4.566

3.  Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes.

Authors:  Yanfei Wang; Can Hou; Jonathan Wisler; Kanhaiya Singh; Chao Wu; Zhiguo Xie; Qianjin Lu; Zhiguang Zhou
Journal:  J Diabetes Investig       Date:  2018-06-26       Impact factor: 4.232

Review 4.  Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects.

Authors:  Anna Perrone; Antonio Giovino; Jubina Benny; Federico Martinelli
Journal:  Oxid Med Cell Longev       Date:  2020-03-18       Impact factor: 6.543

Review 5.  Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications.

Authors:  Dawit Zewdu Wondafrash; Asmelash Tesfay Nire'a; Gebrehiwot Gebremedihn Tafere; Desilu Mahari Desta; Demoze Asmerom Berhe; Kaleab Alemayehu Zewdie
Journal:  Diabetes Metab Syndr Obes       Date:  2020-01-07       Impact factor: 3.168

6.  Quantitative assessment of vascular density in diabetic retinopathy subtypes with optical coherence tomography angiography.

Authors:  Fariba Ghassemi; Kaveh Fadakar; Sahar Berijani; Ameneh Babeli; Alireza Gholizadeh; Siamak Sabour
Journal:  BMC Ophthalmol       Date:  2021-02-12       Impact factor: 2.209

7.  Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

Authors:  Hai-Bing Ju; Fu-Xian Zhang; Shuang Wang; Jie Song; Tao Cui; Li-Feng Li; Hai-Yan Zhang
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

8.  DNMT1-mediated PPARα methylation aggravates damage of retinal tissues in diabetic retinopathy mice.

Authors:  Ying Zhu; Xinru Wang; Xiaoyun Zhou; Lexi Ding; Dan Liu; Huizhuo Xu
Journal:  Biol Res       Date:  2021-08-06       Impact factor: 5.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.